CRIVELLARO, CINZIA
 Distribuzione geografica
Continente #
NA - Nord America 8.050
AS - Asia 4.469
EU - Europa 4.254
SA - Sud America 738
AF - Africa 81
OC - Oceania 33
Continente sconosciuto - Info sul continente non disponibili 13
Totale 17.638
Nazione #
US - Stati Uniti d'America 7.827
SG - Singapore 1.523
IT - Italia 1.216
CN - Cina 1.092
VN - Vietnam 870
BR - Brasile 620
DE - Germania 614
RU - Federazione Russa 608
HK - Hong Kong 500
SE - Svezia 449
IE - Irlanda 312
GB - Regno Unito 226
UA - Ucraina 193
CA - Canada 164
FR - Francia 119
AT - Austria 116
IN - India 110
FI - Finlandia 88
DK - Danimarca 62
KR - Corea 56
TR - Turchia 52
NL - Olanda 50
PL - Polonia 50
BD - Bangladesh 42
AR - Argentina 41
ES - Italia 40
MX - Messico 40
ID - Indonesia 38
JP - Giappone 37
IQ - Iraq 33
ZA - Sudafrica 33
AU - Australia 31
EC - Ecuador 28
BE - Belgio 26
CZ - Repubblica Ceca 22
CH - Svizzera 17
PY - Paraguay 15
PK - Pakistan 13
KE - Kenya 11
BG - Bulgaria 10
LT - Lituania 10
UZ - Uzbekistan 10
CO - Colombia 9
AE - Emirati Arabi Uniti 8
IR - Iran 8
JO - Giordania 8
MA - Marocco 8
VE - Venezuela 8
EU - Europa 7
AZ - Azerbaigian 6
CL - Cile 6
EG - Egitto 6
TN - Tunisia 6
IL - Israele 5
JM - Giamaica 5
OM - Oman 5
PT - Portogallo 5
SA - Arabia Saudita 5
TW - Taiwan 5
A2 - ???statistics.table.value.countryCode.A2??? 4
BO - Bolivia 4
DO - Repubblica Dominicana 4
GE - Georgia 4
GR - Grecia 4
KZ - Kazakistan 4
LB - Libano 4
LK - Sri Lanka 4
RO - Romania 4
SC - Seychelles 4
UY - Uruguay 4
DZ - Algeria 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
MO - Macao, regione amministrativa speciale della Cina 3
NP - Nepal 3
PE - Perù 3
PH - Filippine 3
TH - Thailandia 3
AM - Armenia 2
CR - Costa Rica 2
GA - Gabon 2
GD - Grenada 2
KG - Kirghizistan 2
KW - Kuwait 2
MD - Moldavia 2
MK - Macedonia 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SN - Senegal 2
XK - ???statistics.table.value.countryCode.XK??? 2
AL - Albania 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
CG - Congo 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
Totale 17.627
Città #
Ann Arbor 1.578
Singapore 936
Ashburn 827
Hong Kong 477
Chandler 466
Fairfield 455
Woodbridge 415
Milan 384
Frankfurt am Main 374
Wilmington 359
Houston 343
Dublin 298
Ho Chi Minh City 280
Dearborn 234
New York 207
Seattle 193
Hanoi 190
Dallas 186
Santa Clara 176
Beijing 171
Jacksonville 169
Cambridge 161
Los Angeles 153
Hefei 117
Princeton 111
Shanghai 106
Lissone 100
Vienna 98
Nanjing 86
São Paulo 66
Munich 62
Buffalo 56
Altamura 51
The Dalles 51
Chicago 49
Lawrence 49
Moscow 49
Seoul 48
London 42
Guangzhou 39
Fremont 38
Boardman 37
Monza 37
Montreal 35
Council Bluffs 34
Ottawa 32
San Diego 32
Da Nang 31
Warsaw 31
Rome 30
Toronto 30
Jakarta 29
Nanchang 29
Brooklyn 27
Helsinki 27
Lachine 27
Nuremberg 27
Tokyo 27
Falls Church 26
Atlanta 25
Amsterdam 23
Chennai 23
Jinan 23
Johannesburg 23
Turku 23
Shenyang 22
Stockholm 22
Brussels 21
Dong Ket 21
Ha Long 21
Haiphong 20
Poplar 20
Orem 19
Rio de Janeiro 19
Andover 18
Denver 18
Hangzhou 18
Kunming 18
Tianjin 18
Biên Hòa 17
Boston 17
Brno 17
Ningbo 17
Pune 17
Salt Lake City 16
Ninh Bình 15
Phoenix 15
Changsha 14
Columbus 14
Genoa 14
Melbourne 14
Bắc Ninh 13
Edmonton 13
Manchester 13
Mexico City 13
Mumbai 13
Quận Bình Thạnh 13
Thái Nguyên 13
Brasília 12
Kraków 12
Totale 11.515
Nome #
Treatment response assessment in [18F]FDG-PET/CT oncology scans: Impact of count statistics variation and reconstruction protocol 478
Cognitive profile and metabolic brain imaging in late-onset PCA compared with early-onset PCA and senile amnesic AD 462
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 417
Radiomics of the primary tumour as a tool to improve 18F-FDG-PET sensitivity in detecting nodal metastases in endometrial cancer 415
18F-FDG PET/CT in a Case of Metastatic Breast Cancer to the Vulva 404
18F-FDG-PET/CT guiding to diagnosis of neurosarcoidosis 393
Combining positron emission tomography/computed tomography, radiomics, and sentinel lymph node mapping for nodal staging of endometrial cancer patients 388
Added diagnostic value of respiratory-gated 4D 18F–FDG PET/CT in the detection of liver lesions: a multicenter study 378
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 373
Role of 18F-fluoro-2-deoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in malignant ovarian germ cell tumors: a single-center experience with long term follow-up 371
Cardiotoxicity in breast cancer patients: the role of gated myocardial perfusion SPECT 350
18F-FDG PET/CT in preoperative staging of vulvar cancer patients: Is it really effective? 317
Staging of High-Risk Endometrial Cancer With PET/CT and Sentinel Lymph Node Mapping 316
18F-FDG PET/CT can predict nodal metastases but not recurrence in early stage uterine cervical cancer 308
Impact of Indocyanine Green for Sentinel Lymph Node Mapping in Early Stage Endometrial and Cervical Cancer: Comparison with Conventional Radiotracer 99mTc and/or Blue Dye 307
Quality of Care for Cervical and Endometrial Cancer Patients: The Impact of Different Techniques of Sentinel Lymph Node Mapping on Patient Satisfaction 304
Respiratory motion management in PET/CT: applications and clinical usefulness 300
Sentinel node biopsy in endometrial cancer: an update 297
Sentinel-node mapping in endometrial cancer patients: comparing SPECT/CT, gamma-probe and dye 295
From Conventional Radiotracer Tc-99m with Blue Dye to Indocyanine Green Fluorescence: A Comparison of Methods Towards Optimization of Sentinel Lymph Node Mapping in Early Stage Cervical Cancer for a Laparoscopic Approach 295
Motion management in PET/CT: Technological solutions 295
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 290
Anatomical correlates of reading in the elderly brain: an FDG-PET analysis of the reading performance in Alzheimer's Disease 283
Neurocognitive heterogeneity of Posterior Cortical Atrophy 281
Preoperative staging of cervical cancer: is 18-FDG-PET/CT really effective in patients with early stage disease? 279
Tailoring systematic lymphadenectomy in high-risk clinical early stage endometrial cancer: the role of 18F-FDG PET/CT 273
Baseline 18FDG-PET Metabolic Tumour Volume (MTV) as a Potential Predictive Factor of Response to Metronomic Chemotherapy (mCHT) in HR+/HER2- Metastatic Breast Cancer (MBC) Patients (pts). Preliminary Results of the Metro-pet Study 270
Preoperative 18F-FDG PET/CT in the management of advanced epithelial ovarian cancer 270
Predictive value of 18F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study 268
The heterogeneity of lung perfusion patterns in SPECT/CT during COVID-19: not only embolism 263
The "digital biopsy" in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET/CT 262
Mapping category fluency to the ventral and dorsal language streams in PCA and semantic and logopenic PPA 258
Detection of nodal metastases by 18F-FDG PET/CT in apparent early stage ovarian cancer: a prospective study 252
An optimized protocol for correlation of PET-FDG and pCASL data in mild cognitive impairment (MCI) patients 248
Validity of cingulate–precuneus–temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer’s Disease 247
Clinical applicability of pCASL as a substitute for FDG-PET in the etiological diagnosis of MCI and SCD: CAPE study protocol 244
Role of PET/CT in the clinical management of locally advanced pancreatic cancer 240
Metabolic subtypes of Posterior Cortical Atrophy: a data-driven approach controlling for pathophysiology-related hypometabolism 239
11C-choline PET/CT as a guide to radiation treatment planning of lymph-node relapses in prostate cancer patients 229
Metabolic parameters as biomarkers of response to immunotherapy and prognosis in non-small cell lung cancer (Nsclc): A real world experience 229
Unusual presentation of sarcoid-like reaction on bone marrow level associated with mediastinal lymphadenopathy on 18F-FDG-PET/CT resembling an early recurrence of Hodgkin's Lymphoma 227
Intrathoracic splenosis: Evaluation by 99mTc-labelled heat-denatured erythrocyte SPECT/CT 219
[ 11C]Choline PET/CT detection of bone metastases in patients with PSA progression after primary treatment for prostate cancer: Comparison with bone scintigraphy 217
Comparative analysis of iterative reconstruction algorithms with resolution recovery for cardiac SPECT studies. A multi-center phantom study 217
Clinical and metabolic imaging features of late-onset and early-onset Posterior Cortical Atrophy 212
Focal bone lesions in hiv-positive patient treated with tenofovir 210
Left and right corticobasal syndrome: comparison of cognitive profiles between metabolic imaging - matched groups 207
Integrated PET/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer 206
Contained rupture of common iliac artery aneurysm in a contrast-enhanced PET/CT study 205
Indocyanine Green versus Radiotracer with or without Blue Dye for Sentinel Lymph Node Mapping in Stage >IB1 Cervical Cancer (>2 cm) 202
Cognitive profile of right and left Corticobasal Syndrome 195
Validation of brain 18FDG-PET and pCASL joint analysis tool: a ROI-based approach 195
Clinical and neuroimaging characterization of the first frontotemporal dementia family carrying the MAPT p.K298E mutation 194
Clinical Application of a High Sensitivity BGO PET/CT Scanner: Effects of Acquisition Protocols and Reconstruction Parameters on Lesions Quantification 194
Depressive Pseudodementia with Reversible AD-like Brain Hypometabolism: A Case Report and a Review of the Literature 190
Assessment of nodal status by 18F-FDG PET/CT in early stage ovarian cancer 190
Real-Time Fluorescent Sentinel Lymph Node Mapping with Indocyanine Green in Women with Previous Conization Undergoing Laparoscopic Surgery for Early Invasive Cervical Cancer: Comparison with Radiotracer ± Blue Dye 190
PET/CT and contrast enhanced CT in single vs. two separate sessions: a cost analysis study 186
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line 185
PET-CT for treatment planning in prostate cancer 181
Learning From Mistakes: Cognitive and Metabolic Correlates of Errors on Picture Naming in the Alzheimer's Disease Spectrum 170
Clinical evidence on PET/CT for radiation therapy planning in prostate cancer 167
Comment on 'Pre-operative nomogram for the identification of lymph node metastasis in early cervical cancer' 166
Molecular imaging in prostate cancer: [11C]choline PET/CT 160
Performance of a SPECT collimator-detector response reconstruction algorithm: phantom studies and validation in inflammation clinical studies 150
Reduced phonemic fluency in progressive supranuclear palsy is due to dysfunction of dominant BA6 145
Cervical injection for sentinel lymph nodes detection in endometrial cancers is controversial: response to comments 143
A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: validation on 18F-FDG PET data 141
A cognitive marker for Alzheimer disease pathology in primary progressive aphasia? A validation study in the clinical setting 139
Respiratory Gating and the performance of PET/CT in pulmonary lesions 139
PET-Guided target delineation in a patient with lung cancer. 111
Guidelines for the screening and follow-up of infants born to anti-HCV positive mothers 67
Identification of Alzheimer’s disease with 18F-FDG-PET and MRI pCASL in MCI and SCD subjects: the CAPE study 54
Next-generation radiomic sequencing in non-small cell lung cancer: an alternative model to predict mutations from [18F]FDG PET/CT 27
Totale 18.189
Categoria #
all - tutte 55.983
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 55.983


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.119 0 0 0 0 0 183 147 180 142 156 141 170
2021/20221.107 107 140 110 116 64 71 56 54 53 92 99 145
2022/20231.834 182 531 152 219 112 281 13 108 97 45 53 41
2023/20241.307 53 54 74 77 140 294 235 70 67 38 21 184
2024/20253.179 155 334 169 136 207 181 236 112 273 582 307 487
2025/20265.136 1.401 623 686 1.002 1.040 384 0 0 0 0 0 0
Totale 18.189